Identification of axonal involvement in Hallervorden-Spatz disease with magnetic resonance spectroscopy

被引:5
|
作者
Kitis, O.
Tekgul, H. [1 ]
Erdemir, G.
Polat, M.
Serdaroglu, G.
Tosun, A.
Coker, M.
Gokben, S.
机构
[1] Ege Univ Hosp, Dept Pediat, Div Pediat Neurol, TR-35100 Izmir, Turkey
[2] Ege Univ Hosp, Dept Radiol, Div Neuroradiol, TR-35100 Izmir, Turkey
[3] Ege Univ Hosp, Dept Pediat, Div Endocrinol & Metab, TR-35100 Izmir, Turkey
关键词
Hallervorden-Spatz syndrome; neurodegenerative diseases; magnetic resonance imaging; magnetic resonance spectroscopy;
D O I
10.1016/S0150-9861(06)77244-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Hallervorden-Spatz disease is a neurodegenerative disorder associated with cysteine-iron complex accumulation typically seen as bilateral symmetrical hypointense signal changes in the medial globus pallidus on magnetic resonance imaging. We used magnetic resonance spectroscopy to identify and quantify neuronal damage in two siblings with Hallervorden-Spatz disease. The first patient presenting with a rapidly progressive extrapyramidal syndrome had markedly decreased Nacetylaspartate (NAA) to creatinine (Cr) ratios in the globus pallidi and the periatrial white matter. He also had increased myoinositol (ml) to creatinine (Cr) ratios implying glial proliferation in the affected regions. However the second patient who had the initial presentation of disease had normal NAA/Cr and ml/Cr ratios. These findings indicate that the quantification of NAA:Cr and ml:Cr ratios might be used to predict the extent of neuronal axonal loss and glial proliferation in patients with Hallervorden-Spatz disease respectively.
引用
收藏
页码:129 / 132
页数:4
相关论文
共 50 条
  • [31] Psychotic disorder in a case with Hallervorden-Spatz disease
    Öner, Ö
    Öner, P
    Deda, G
    Içagasioglu, D
    ACTA PSYCHIATRICA SCANDINAVICA, 2003, 108 (05) : 394 - 397
  • [32] MR IMAGING IN A CASE OF HALLERVORDEN-SPATZ DISEASE
    TANFANI, G
    MASCALCHI, M
    DALPOZZO, GC
    TAVERNI, N
    SAIA, A
    TREVISAN, C
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1987, 11 (06) : 1057 - 1058
  • [33] MR IMAGING IN A CASE OF HALLERVORDEN-SPATZ DISEASE
    PEDESPAN, JM
    FONTAN, D
    CASTELL, JF
    LANGLADE, P
    GUILLARD, JM
    ARCHIVES FRANCAISES DE PEDIATRIE, 1993, 50 (01): : 35 - 37
  • [34] NEUROPSYCHOLOGICAL PERFORMANCE IN PUTATIVE HALLERVORDEN-SPATZ DISEASE
    LORING, DW
    SETHI, KD
    FALLON, JH
    MEADOR, KJ
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1987, 9 (01) : 48 - 49
  • [35] In vivo diagnosis of Hallervorden-Spatz disease - Reply
    Ostergaard, JR
    Christensen, T
    Hansen, IN
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 1996, 38 (04): : 372 - 373
  • [36] Cervical myelopathy in an adolescent with Hallervorden-Spatz disease
    Fung, GPG
    Chan, KY
    PEDIATRIC NEUROLOGY, 2003, 29 (04) : 337 - 340
  • [37] COMPUTED-TOMOGRAPHY IN HALLERVORDEN-SPATZ DISEASE
    BOLTSHAUSER, E
    LANG, W
    JANZER, R
    BRINER, J
    SPIESS, H
    KLEIHUES, P
    ISLER, W
    NEUROPEDIATRICS, 1987, 18 (02) : 81 - 83
  • [38] Hallervorden-Spatz disease: Late infantile type
    Singhi, PD
    Mitra, S
    JOURNAL OF CHILD NEUROLOGY, 1997, 12 (04) : 281 - 282
  • [39] How broad is the phenotype of Hallervorden-Spatz disease?
    Hickman, SJ
    Ward, NS
    Surtees, RAH
    Stevens, JM
    Farmer, SF
    ACTA NEUROLOGICA SCANDINAVICA, 2001, 103 (03): : 201 - 203
  • [40] HALLERVORDEN-SPATZ DISEASE - MR AND PATHOLOGICAL FINDINGS
    SAVOIARDO, M
    HALLIDAY, WC
    NARDOCCI, N
    STRADA, L
    DINCERTI, L
    ANGELINI, L
    RUMI, V
    TESOROTESS, JD
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1993, 14 (01) : 155 - 162